CU23879B1 - - Google Patents

Info

Publication number
CU23879B1
CU23879B1 CU20090172A CU20090172A CU23879B1 CU 23879 B1 CU23879 B1 CU 23879B1 CU 20090172 A CU20090172 A CU 20090172A CU 20090172 A CU20090172 A CU 20090172A CU 23879 B1 CU23879 B1 CU 23879B1
Authority
CU
Cuba
Application number
CU20090172A
Other versions
CU20090172A6 (es
CU20090172A7 (es
Inventor
Reyes Yamila Verdecia
Rodríguez Estael Ochoa
Reyes Alberto Ruiz
Figueredo Yanier Núñez
Domínguez Carmen Carrillo
Morales Juan Enrique Tacoronte
Gutiérrez Livan Lázaro Alba
Andreu Gilberto Lázaro Pardo
Original Assignee
Ct De Investigación Y Desarrollo De Medicamentos
Síntesis Orgánica De La Facultad De Química De La Universidad De La Habana Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Investigación Y Desarrollo De Medicamentos, Síntesis Orgánica De La Facultad De Química De La Universidad De La Habana Lab De filed Critical Ct De Investigación Y Desarrollo De Medicamentos
Priority to CUP2009000172A priority Critical patent/CU20090172A7/es
Priority to KR1020127011917A priority patent/KR20120093940A/ko
Priority to EP10821598.9A priority patent/EP2487174A4/en
Priority to US13/500,983 priority patent/US9315497B2/en
Priority to CN2010800556597A priority patent/CN102656171A/zh
Priority to CA2777209A priority patent/CA2777209C/en
Priority to PCT/CU2010/000004 priority patent/WO2011041989A2/es
Priority to JP2012532450A priority patent/JP2013507329A/ja
Publication of CU20090172A6 publication Critical patent/CU20090172A6/es
Publication of CU20090172A7 publication Critical patent/CU20090172A7/es
Priority to ZA2012/03295A priority patent/ZA201203295B/en
Publication of CU23879B1 publication Critical patent/CU23879B1/es
Priority to US14/282,111 priority patent/US10138231B2/en
Priority to US16/171,046 priority patent/US20190092769A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CUP2009000172A 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular CU20090172A7 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CUP2009000172A CU20090172A7 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
CA2777209A CA2777209C (en) 2009-10-09 2010-10-08 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
EP10821598.9A EP2487174A4 (en) 2009-10-09 2010-10-08 TRICYCLIC AND TETRACYCLIC SYSTEMS WITH EFFECT ON THE CENTRAL NERVOUS AND VACUUM SYSTEM
US13/500,983 US9315497B2 (en) 2009-10-09 2010-10-08 Tricyclic and tetracyclic systems with activity on the central nervous and vascular systems
CN2010800556597A CN102656171A (zh) 2009-10-09 2010-10-08 对血管系统和中枢神经系统起作用的三环和四环系统
KR1020127011917A KR20120093940A (ko) 2009-10-09 2010-10-08 중추신경계 및 혈관계에 대한 활성을 갖는 트리시클릭 및 테트라시클릭 시스템
PCT/CU2010/000004 WO2011041989A2 (es) 2009-10-09 2010-10-08 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
JP2012532450A JP2013507329A (ja) 2009-10-09 2010-10-08 脈管系および中枢神経系に作用する三環系化合物および四環系化合物
ZA2012/03295A ZA201203295B (en) 2009-10-09 2012-05-07 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
US14/282,111 US10138231B2 (en) 2009-10-09 2014-05-20 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems
US16/171,046 US20190092769A1 (en) 2009-10-09 2018-10-25 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CUP2009000172A CU20090172A7 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Publications (3)

Publication Number Publication Date
CU20090172A6 CU20090172A6 (es) 2011-10-05
CU20090172A7 CU20090172A7 (es) 2011-10-05
CU23879B1 true CU23879B1 (es) 2013-04-19

Family

ID=45000047

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2009000172A CU20090172A7 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Country Status (9)

Country Link
US (3) US9315497B2 (es)
EP (1) EP2487174A4 (es)
JP (1) JP2013507329A (es)
KR (1) KR20120093940A (es)
CN (1) CN102656171A (es)
CA (1) CA2777209C (es)
CU (1) CU20090172A7 (es)
WO (1) WO2011041989A2 (es)
ZA (1) ZA201203295B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017190713A1 (es) * 2016-05-04 2017-11-09 Universidad De La Habana Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201215033D0 (en) 2012-08-23 2012-10-10 Novartis Ag Diazepinone derivatives
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
CU20190114A7 (es) 2019-12-26 2021-08-06 Centro De Investig Y Desarrollo De Medicamentos Cidem Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física
WO2022055168A1 (ko) * 2020-09-09 2022-03-17 서울대학교산학협력단 신규 피리미도디아제핀 유도체 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780047A (en) 1972-07-05 1973-12-18 Squibb & Sons Inc Derivatives of pyrazolo(3',4'-2,3)pyrido(4,5-e)b-benzo-1,5-diazepines
US4012373A (en) 1972-09-22 1977-03-15 E. R. Squibb & Sons, Inc. Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones
US4970207A (en) 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
US5571809A (en) * 1989-04-20 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. The treatment of HIV-1 infection using certain pyridodiazepines
EP0491218A1 (en) 1990-12-17 1992-06-24 F. Hoffmann-La Roche Ag Benzodiazepinones
ATE143018T1 (de) 1991-02-07 1996-10-15 Boehringer Ingelheim Pharma Pyridobenzodiazepine, dipyrido-(3,2-b:2',3'-3> (1,4>-diazepine und deren verwendung in der vorbeugung und behandlung von aids
GEP20001968B (en) 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
DK0558104T3 (da) 1992-01-21 1999-04-26 Glaxo Wellcome Spa 1,5-Benzodiazepinderivater og deres anvendelse i lægemidler
AU3443593A (en) 1992-02-13 1993-09-03 Upjohn Company, The 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
HU220635B1 (hu) 1994-08-18 2002-03-28 Merck & Co. Inc. 2,3-Dihidro-1-(2,2,2-trifluor-etil)-2-oxo-5-fenil-1H-1,4-benzodiazepin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
WO1996006606A1 (en) 1994-08-31 1996-03-07 Eli Lilly And Company Dihydro-2,3-benzodiazepine derivatives
EG24221A (en) 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US7745431B2 (en) 2002-12-03 2010-06-29 Vela Acquisition Corporation Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017190713A1 (es) * 2016-05-04 2017-11-09 Universidad De La Habana Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular
CN110114356A (zh) * 2016-05-04 2019-08-09 哈瓦那大学 具有对中枢神经系统和血管系统的活性的苯并二氮卓衍生物

Also Published As

Publication number Publication date
JP2013507329A (ja) 2013-03-04
CU20090172A6 (es) 2011-10-05
CA2777209A1 (en) 2011-04-14
CU20090172A7 (es) 2011-10-05
US9315497B2 (en) 2016-04-19
US20190092769A1 (en) 2019-03-28
KR20120093940A (ko) 2012-08-23
ZA201203295B (en) 2014-10-29
WO2011041989A2 (es) 2011-04-14
CN102656171A (zh) 2012-09-05
CA2777209C (en) 2016-11-22
EP2487174A2 (en) 2012-08-15
EP2487174A4 (en) 2013-05-08
US20140275042A1 (en) 2014-09-18
US20120202791A1 (en) 2012-08-09
US10138231B2 (en) 2018-11-27
WO2011041989A3 (es) 2011-09-15

Similar Documents

Publication Publication Date Title
BR112012012396A2 (es)
BR112012008267A2 (es)
BR112012003062A2 (es)
BR112012008195A2 (es)
BRPI0925311A2 (es)
BRPI0924307A2 (es)
BR122021004633A2 (es)
BR112012003080A2 (es)
BR122017024704A2 (es)
BR112012012487A2 (es)
BR112012000665A2 (es)
BR112012003853A2 (es)
BR112012012080A2 (es)
BR112012009797A2 (es)
BR112012009446A2 (es)
BR112012009703A2 (es)
BR112012010357A2 (es)
BR112012007656A2 (es)
BR122019005883A2 (es)
BR112012002627A2 (es)
BR112012001263A2 (es)
BR112012000159A2 (es)
BR112012014856A2 (es)
BRPI0924534A2 (es)
BR112012007654A2 (es)

Legal Events

Date Code Title Description
FG Grant of patent